EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A mitochondrion-targeted cyanine agent for NIR-II fluorescence-guided surgery combined with intraoperative photothermal therapy to reduce prostate cancer recurrence

Chenchen Liu, Zong Chang, Kailei Chen, Qiang Xue, Bingxin Shu, Zhihao Wei, Xuan Zhou, Like Guo, Yuling Zhang, Yingying Pan, Qi Cao, Huageng Liang und 2 weitere

Journal of Nanobiotechnology · 2024

DOI: 10.1186/s12951-024-02477-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nanobiotechnology, 2024. Verfasst von Chenchen Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Photothermal Therapy, Mitochondria, Carbocyanines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poorly identified tumor boundaries and nontargeted therapies lead to the high recurrence rates and poor quality of life of prostate cancer patients. Near-infrared-II (NIR-II) fluorescence imaging provides certain advantages, including high resolution and the sensitive detection of tumor boundaries. Herein, a cyanine agent (CY7-4) with significantly greater tumor affinity and blood circulation time than indocyanine green was screened. By binding albumin, the absorbance of CY7-4 in an aqueous solution showed no effects from aggregation, with a peak absorbance at 830 nm and a strong fluorescence emission tail beyond 1000 nm. Due to its extended circulation time (half-life of 2.5 h) and high affinity for tumor cells, this fluorophore was used for primary and metastatic tumor diagnosis and continuous monitoring. Moreover, a high tumor signal-to-noise ratio (up to ~ 10) and excellent preferential mitochondrial accumulation ensured the efficacy of this molecule for photothermal therapy. Therefore, we integrated NIR-II fluorescence-guided surgery and intraoperative photothermal therapy to overcome the shortcomings of a single treatment modality. A significant reduction in recurrence and an improved survival rate were observed, indicating that the concept of intraoperative combination therapy has potential for the precise clinical treatment of prostate cancer. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsPhotothermal TherapyMitochondriaCarbocyaninesNeoplasm Recurrence, LocalMaleHumansAnimalsCell Line, TumorOptical ImagingMiceSurgery, Computer-AssistedFluorescent DyesMice, NudeMice, Inbred BALB CInfrared RaysIndocyanine Green

Stichwörter der Autor:innen

Fluorescence-guided surgeryIntraoperative interventionPhotothermal therapyProstate cancerRecurrence

Substanzen

CarbocyaninesFluorescent DyesIndocyanine Green

Autor:innen und Institutionen

  • Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • Institute of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • Guangdong Provincial Key Laboratory of Biomedical Optical Imaging Technology & Center for Biomedical Optics and Molecular Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Science, Shenzhen, 518055,…
  • Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. xzhang@hust.edu.cn.
  • Institute of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. xzhang@hust.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, C., Chang, Z., Chen, K., Xue, Q., Shu, B., Wei, Z., Zhou, X., Guo, L., Zhang, Y., Pan, Y., Cao, Q., Liang, H., Sun, Q., & Zhang, X. (2024). A mitochondrion-targeted cyanine agent for NIR-II fluorescence-guided surgery combined with intraoperative photothermal therapy to reduce prostate cancer recurrence. Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-024-02477-6

Vancouver

Liu C, Chang Z, Chen K, Xue Q, Shu B, Wei Z, et al. A mitochondrion-targeted cyanine agent for NIR-II fluorescence-guided surgery combined with intraoperative photothermal therapy to reduce prostate cancer recurrence. Journal of Nanobiotechnology. 2024. doi:10.1186/s12951-024-02477-6

BibTeX
@article{Liu2024,
  author = {Liu, Chenchen and Chang, Zong and Chen, Kailei and Xue, Qiang and Shu, Bingxin and Wei, Zhihao and Zhou, Xuan and Guo, Like and Zhang, Yuling and Pan, Yingying and Cao, Qi and Liang, Huageng and Sun, Qinchao and Zhang, Xiaoping},
  title = {A mitochondrion-targeted cyanine agent for NIR-II fluorescence-guided surgery combined with intraoperative photothermal therapy to reduce prostate cancer recurrence},
  journal = {Journal of Nanobiotechnology},
  year = {2024},
  doi = {10.1186/s12951-024-02477-6}
}
Kostenlos starten →